The zebrafish is a common alternative model in cardiovascular research due to its heart formation being similar to that of the human heart.
Cardiovascular disease is the main cause of death in the world, with 17.9 million people dying each year (World Health Organization), representing 32% of all deaths in the world.
There are several forms of heart disease, including coronary heart disease and cerebrovascular disease. Over four out of five deaths due to a coronary disorder are caused by a heart attack or a stroke, and a third of these take place in people under 70 years of age.
These data reveal the importance of finding a cure to treat heart diseases as soon as possible.
The zebrafish heart is very similar to a human heart, reason why it is a suitable model to study human heart diseases.
The human heart is made up of four chambers, two on the left and two on the right. When damage occurs to the heart (through cardiovascular disease or a heart attack) the cells in the heart are damaged and do not reproduce.
Although the zebrafish heart only contains two chambers, these are very similar to the human heart, making it a suitable model to study human heart disease.
The advantages of using the zebrafish for cardiac study include:
General advantages of zebrafish for medical research include:
The heart is the first organ to form and function in the zebrafish and it develops in the same manner as in the human heart.
As the heart forms, it is possible to study and identify any defects that may form due to the transparency of the embryo. This allows researching one of the most common forms of birth defects in humans – congenital heart defects.
This model also makes it possible to study blood flow and the effects in the heart when it reduces.
Zebrafish is used in many ways to study heart disease and to research new treatments, for example:
The use of zebrafish in cardiovascular studies is an important part of pharmaceutical research and the sooner we can find cures and treatments for heart disease, the sooner the number of human deaths worldwide could be reduced. At Biobide we perform the cardiotoxicity assay that allows detecting cardiac arrhythmias in zebrafish larvae, that resembles QT prolongation effects in humans. This allows for selecting safer candidates without cardiotoxicities that can be life-threatening.
Sources